Skip to content

Interface

Active
Non-profit association·Activiteiten van verpleegkundigen en verloskundigen· 4 yrs active
Hippokrateslaan 10 ·1200 Sint-Lambrechts-Woluwe, Belgium
KBO/BCE: BE 0777.598.817
Watch Print / PDF
Age4 yrs
Board4

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Interface is < 0.1% (very low). The 2024 annual accounts show equity of €6k and a net result of €-335. Equity is growing by ~773.1% per year across the filed fiscal years. Its solvency ranks better than 10% of 257 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
< 0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-risk legal form Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Signals

1 signal · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 257 sector peers (2024).
View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 16 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2025, 30 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 01-07-2025 30 d early 2025-00208012
31-12-2023 31-07-2024 27-06-2024 34 d early 2024-00168426
31-12-2022 31-07-2023 28-09-2023 59 d late 2023-00456851

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

Turnover€23k-16.7%
EBIT margin0.0%-156.8pp
Net result€-335
Working capital€283k+228.8%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 01-07-2025 with the NBB · fiscal year 2024 · volledig
€-100k€-50k€0€50kRevenue 2022: €11k€11kOperating result 2022: €-96k€-96kNet result 2022: €-96k€-96kRevenue 2023: €28k€28kOperating result 2023: €43k€43kNet result 2023: €43k€43kRevenue 2024: €23k€23kOperating result 2024: €1€1Net result 2024: €-335€-335202220232024
RevenueOperating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Net result: growth of ~111.9%/year over 3 fiscal years, indicative, assuming unchanged policy.
€-100k€0€100k2025: €48k (€48k - €48k)2026: €96k (€96k - €96k)2027: €143k (€143k - €144k)2022: €-96k2023: €43k2024: €-335202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency 1.7% 49.4%
better than 10% of 257 sector peers
Net result €-335 €51k
better than 14% of 256 sector peers
Equity €6k €126k
better than 11% of 257 sector peers
Gross operating margin €415k €147k
better than 75% of 252 sector peers
Staff costs €415k €159k
higher than 66% of 116 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P10
2022: P5 · n=1992023: P8 · n=2262024: P10 · n=2572022 2024
Stable position over 2022-2024 · n=199-257
Net result P14
2022: P5 · n=1992023: P47 · n=2242024: P14 · n=2562022 2024
Stable position over 2022-2024 · n=199-256
Equity P11
2022: P5 · n=1992023: P9 · n=2262024: P11 · n=2572022 2024
Stable position over 2022-2024 · n=199-257
Gross operating margin P75
2022: P63 · n=1962023: P74 · n=2222024: P75 · n=2522022 2024
Improving position over 2022-2024 · n=196-252
Describes the position versus peers, not a forecast.
Revenue
€23k
-16.7% 22-24
EBITDA
€25
- 22-24
Net profit
€-335
- 22-24
Cash flow
€-311
- 22-24
Total assets
€362k
+165.7% 22-24
Equity
€6k
-5.1% 22-24
Working capital
€283k
+228.8% 22-24
Employees (FTE)
4
- 22-24
Show 13 other metrics
Staff costs
€415k
-1.4% 22-24
Debt
€356k
+174.5% 22-24
Debt ≤ 1y
€76k
+52.4% 22-24
Debt > 1y
€280k
+250.7% 22-24
Current ratio
4.74
+73.4% 22-24
Quick ratio
4.74
+73.4% 22-24
Solvency
1.7%
-64.3% 22-24
Debt / equity
56.48
+189.1% 22-24
ROE
-5.3%
- 22-24
ROA
-0.1%
- 22-24
Net margin
-1.5%
- 22-24
EBITDA margin
0.1%
- 22-24
Interest coverage
0.07
- 22-24
Figures by fiscal year
Fiscal year2024
Depositvolledig
Revenue€23k
EBITDA€25
Net profit€-335
Cash flow€-311
Staff costs€415k
Income taxes-
Dividends-
Total assets€362k
Equity€6k
Debt€356k
of which ≤ 1y€76k
of which > 1y€280k
Working capital€283k
Employees (FTE)-
Ratios (computed)
2024
Current ratio4.74
Quick ratio4.74
Working capital ratio78.2%
Solvency1.7%
Debt / equity56.48
Long-term debt ratio44.44
Interest coverage0.07
Gross margin-72.3%
Net margin-1.5%
ROA-0.1%
ROE-5.3%
EBITDA margin0.1%
Days sales outstanding73d
Days payable outstanding698d
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (21 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€362k
Fixed assets 21/28€3k
Tangible fixed assets 22/27€3k
Financial fixed assets 28€363
Current assets 29/58€359k
Amounts receivable within one year 40/41€5k
Cash & bank 54/58€275k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€362k
Equity 10/15€6k
Accumulated profits (losses) 14€6k
Amounts payable 17/49€356k
Amounts payable after one year 17€280k
Amounts payable within one year 42/48€76k
Trade debts payable within one year 44€76k
Income statement
Turnover 70€23k
Gross operating margin 9900€415k
Operating result 9901€1
Financial charges 65€336
Result before taxes 9903€-335
Net result for the period 9904€-335
Result to be appropriated 9905€-335
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
34 / 100 Weak
050100
Computed from 6 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

7 directors
Current directors & mandates
  • Claire Dufour
    Director
    State Gazette act 25142133 (06-11-2025)
    Current
    06-11-2025 → present
  • Delphine Misko
    Director
    State Gazette act 25142133 (06-11-2025)
    Current
    06-11-2025 → present
  • Alexandra COULON
    Director
    State Gazette act 24111580 (23-07-2024)
    Current
    26-06-2024 → present
  • Manuel De SCHUITENEER
    Director
    State Gazette act 24111580 (23-07-2024)
    Current
    26-06-2024 → present
Former directors (3)
  • Maud Onockx
    Director
    State Gazette act 25142133 (06-11-2025)
    Former
    - → 06-11-2025
  • Marianne Desmedt
    Director
    State Gazette act 24111580 (23-07-2024)
    Former
    26-04-2023 → 26-06-2024
    2 events
    • 26-06-2024 Resigned· Director
    • 26-04-2023 Appointed· Director
  • Laurent Knoops
    Director
    State Gazette act 24111580 (23-07-2024)
    Former
    - → 21-03-2023
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Activiteiten van verpleegkundigen en verloskundigen(86940)
Legal form Non-profit association(017)
Incorporation23-11-2021
StatusActive
Postal code1200

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hippokrateslaan 101200 Sint-Lambrechts-Woluwe

Establishment units

1 location
Interface
Hippokrateslaan 10, 1200 Sint-Lambrechts-WoluweVerpleegkundige activiteiten
since 20222.326.464.034
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area5.0 ha

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21018B0078/00R002 Brussels 5.0 ha - -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

4 acts
All acts · 4 updated 9 months ago
2025
06-11-2025 2 directors appointed, 1 resigning Director changes
  • Claire Dufour, Bestuurder
  • Delphine Misko, Bestuurder
  • Maud Onockx, Bestuurder
Summary: v3.2
2024
23-07-2024 3 directors appointed, 2 resigning Director changes
  • Marianne Desmedt, Bestuurder
  • Alexandra COULON, Bestuurder
  • Manuel De SCHUITENEER, Bestuurder
  • Laurent Knoops, Bestuurder
  • Marianne Desmedt, Bestuurder
Summary: v3.2
2021
25-11-2021 Incorporation of a new ASBL Incorporation
Summary: oprichting
25-11-2021 Incorporation of a new VZW Incorporation
Summary: oprichting

Analysis

Financial profile

5 of 5 axes measured
Health34Profitability6Solvency34Growth85Stability94
51 / 100

Mixed profile: strong on stability, weaker on profitability.

All 5 axes are computed from data Checked has read.

Health 34
Profitability 6
Solvency 34
Growth 85
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Verpleegkundige activiteiten86906Activiteiten van verpleegkundigen en verloskundigen86940
Primary activity highlighted.
Names & trade names
Legal nameFR Interface
Legal nameNL Interface
Registered office
Hippokrateslaan 10
1200 Sint-Lambrechts-Woluwe, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.